Pranav R. Santapuram
Piedmont Cancer Institute(US)Winship Cancer Institute
Publications by Year
Research Areas
CAR-T cell therapy research, Ocular Oncology and Treatments, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Retinal Diseases and Treatments
Most-Cited Works
- → Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC(2014)122 cited
- → The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer(2016)83 cited
- → Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007–2017(2018)56 cited
- → Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach(2019)36 cited
- → Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients(2021)17 cited
- → y+ cationic amino acid transport of arginine in packed red blood cells(2012)12 cited
- → Adverse Events, Treatment Burden, and Outcomes of Intravenous versus Intra-arterial Chemotherapy for Retinoblastoma(2020)10 cited
- → The tumor microenvironment of pancreatic adenocarcinoma and immune checkpoint inhibitor resistance: a perplex relationship(2020)6 cited
- → Real-World Analysis of Cytopenias after Chimeric Antigen Receptor T-Cell Therapy: A Comparison of BCMA and CD19 Based Outcomes(2022)3 cited
- → Comparison of outcomes, adverse events, and treatment burden of intravenous chemotherapy versus intra-arterial chemotherapy for retinoblastoma: results of a pilot study(2019)1 cited